CN Patent

CN109743875B — Menin-mll相互作用的抑制剂

Assigned to Vitae Pharmaceuticals LLC · Expires 2022-04-29 · 4y expired

What this patent protects

本发明涉及menin与MLL和MLL融合蛋白的相互作用的抑制剂、含有该抑制剂的药物组合物，以及它们在治疗癌症和由menin‑MLL相互作用介导的其它疾病中的用途。

USPTO Abstract

本发明涉及menin与MLL和MLL融合蛋白的相互作用的抑制剂、含有该抑制剂的药物组合物，以及它们在治疗癌症和由menin‑MLL相互作用介导的其它疾病中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN109743875B
Jurisdiction
CN
Classification
—
Expires
2022-04-29
Drug substance claim
No
Drug product claim
No
Assignee
Vitae Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.